今开:0.0 | 昨收:1.0 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:3.2347584E7 |
usbiostock2018-06-12 22:47
$Pluristem Therapeutics, Inc. (PSTI)$ 公司公布PLX-PAD细胞治疗间歇性跛行临床2期试验结果。试验结果显示,两次注射3亿个PLX-PAD细胞后52周,可显著改善最大步行距离(MWD)。查看全文
usbiostock2018-04-26 00:09
$Pluristem Therapeutics, Inc.(PSTI)$ FDA批准一项有关PLX-PAD细胞疗法的临床3期试验申请,用于治疗髋关节骨折手术修复后的肌肉损伤。查看全文
YanGHuI-2018-01-12 23:20
$Pluristem Therapeutics, Inc.(PSTI)$ Pluristem’s PLX Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study查看全文
YanGHuI-2017-12-09 03:12
$Pluristem Therapeutics, Inc.(PSTI)$ HAIFA, Israel, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (PSTI), a leading developer of placenta-based cell therapy products, announced today the company will present data from its Phase II-equivalent study of PL...查看全文
YanGHuI-2017-12-07 02:14
$Pluristem Therapeutics, Inc.(PSTI)$ HAIFA, Israel, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (PSTI), a leading developer of placenta-based cell therapy products, announced the publication of a peer-reviewed article in Cytotherapy, the official jour...查看全文
$Pluristem疗法(PSTI)$ 8-K Current report, items 5.03, 8.01, and 9.01 Accession Number: 0001213900-22-041096 Act: 34 Size: 3 MB 网页链接
$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-039009 Act: 34 Size: 204 KB 网页链接
$Pluristem疗法(PSTI)$ 8-K Current report, items 5.02 and 5.07 Accession Number: 0001213900-22-034605 Act: 34 Size: 209 KB 网页链接
$Pluristem疗法(PSTI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-22-024864 Act: 34 Size: 3 MB 网页链接
$Pluristem疗法(PSTI)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-22-021895 Act: 34 Size: 1 MB 网页链接
$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-014625 Act: 34 Size: 196 KB 网页链接
$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-010987 Act: 34 Size: 197 KB 网页链接
$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-009545 Act: 34 Size: 203 KB 网页链接
$Pluristem疗法(PSTI)$ 内部交易: 2022-02-10,Director,Aberman Zami ,买入,80616普通股, $1.80
$Pluristem疗法(PSTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-22-007471 Size: 6 KB 网页链接